
Dr. Melaxin Cemenrete Calcium Volume Cream Review
BLC Research Score
A research-based assessment from ingredient and formula analysis plus reputation, not a hands-on lab test. See our scoring approach.
- Best for
- dry, oily, combination, sensitive
- Price
- $26.00 / 1.76 oz
- Main claim
- Anti-aging firming
- Texture
- Rich cream applied to the under-eye area as the last skincare step, morning and
Editorial pick only.
Quick verdict
Dr. Melaxin Cemenrete Calcium Volume Cream sits in the k-beauty tier at $26.00 for 1.76 oz. Best for dry, oily, combination, sensitive skin.
Key ingredients
What the hero actives in Cemenrete Calcium Volume Cream are supposed to do.
Primary
Rebornic
Supporting
Calcium, Vitamin D, Hydrolyzed Elastin, Collagen-supporting complex
Learn more about these actives
Vitamin C
An antioxidant that neutralizes free radicals from UV and pollution, while also brightening dark spots and supporting collagen synthesis.
Read the full Vitamin C guide ->Vitamin E
A fat-soluble antioxidant that neutralizes free radicals from UV and pollution, supports skin barrier function, and keeps the oils in a formula from going rancid.
Read the full Vitamin E guide ->Alternatives to Dr. Melaxin Cemenrete Calcium Volume Cream
Other face creams we have reviewed.
ALASTIN
Soothe + Protect Recovery Balm
$52.00 / Full size
Read review ->Aveeno
Calm + Restore Oat Gel Moisturizer
$19.97 / 1.7 fl oz (50 mL)
Read review ->Avene
Cicalfate+ Restorative Protective Cream
$40.00 / 3.3 fl oz (100ml)
Read review ->Avene
Tolerance Control Soothing Skin Recovery Cream
$40.00 / 1.3 fl oz (40ml)
Read review ->See category roundups:
Final verdict
Dr. Melaxin Cemenrete Calcium Volume Cream is a k-beauty face cream for dry, oily, combination, sensitive skin.
Check price at Dr.Independent. No sponsored placement.
Comparing options? See all our tested picks on the BestLiftingCream.com homepage.
Editor's note
Reviewed by the BLC Editorial Team using our standardized 7-criteria scoring methodology. Independent and not sponsored.
Last updated: Sep 17, 2026. Read how we evaluate.